WallStSmart

Becton Dickinson and Company (BDX)vsLive Nation Entertainment Inc (LYV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Live Nation Entertainment Inc generates 17% more annual revenue ($25.61B vs $21.92B). BDX leads profitability with a 8.0% profit margin vs 0.3%. BDX appears more attractively valued with a PEG of 1.12. BDX earns a higher WallStSmart Score of 63/100 (C+).

BDX

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 5.5Value: 6.7Quality: 5.5
Piotroski: 6/9Altman Z: 1.49

LYV

Hold

42

out of 100

Grade: D

Growth: 5.3Profit: 4.0Value: 4.3Quality: 3.8
Piotroski: 3/9Altman Z: 1.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

BDXUndervalued (+25.3%)

Margin of Safety

+25.3%

Fair Value

$241.89

Current Price

$149.43

$92.46 discount

UndervaluedFair: $241.89Overvalued
LYVUndervalued (+12.2%)

Margin of Safety

+12.2%

Fair Value

$172.04

Current Price

$163.28

$8.76 discount

UndervaluedFair: $172.04Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BDX2 strengths · Avg: 8.0/10
Price/BookValuation
1.7x8/10

Reasonable price relative to book value

EPS GrowthGrowth
28.6%8/10

Earnings expanding 28.6% YoY

LYV1 strengths · Avg: 8.0/10
Free Cash FlowQuality
$2.03B8/10

Generating 2.0B in free cash flow

Areas to Watch

BDX4 concerns · Avg: 3.3/10
P/E RatioValuation
26.8x4/10

Moderate valuation

Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

Return on EquityProfitability
7.0%3/10

ROE of 7.0% — below average capital efficiency

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

LYV4 concerns · Avg: 2.5/10
Profit MarginProfitability
0.3%3/10

0.3% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
6.502/10

Expensive relative to growth rate

Price/BookValuation
140.8x2/10

Trading at 140.8x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : BDX

The strongest argument for BDX centers on Price/Book, EPS Growth. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : LYV

The strongest argument for LYV centers on Free Cash Flow. Revenue growth of 12.2% demonstrates continued momentum.

Bear Case : BDX

The primary concerns for BDX are P/E Ratio, Revenue Growth, Return on Equity.

Bear Case : LYV

The primary concerns for LYV are Profit Margin, Piotroski F-Score, PEG Ratio. Thin 0.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

LYV carries more volatility with a beta of 1.11 — expect wider price swings.

LYV is growing revenue faster at 12.2% — sustainability is the question.

LYV generates stronger free cash flow (2.0B), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

BDX scores higher overall (63/100 vs 42/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Becton Dickinson and Company

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Visit Website →

Live Nation Entertainment Inc

COMMUNICATION SERVICES · ENTERTAINMENT · USA

Live Nation Entertainment, Inc is an American global entertainment company, founded in 2010, following the merger of Live Nation and Ticketmaster. The company promotes, operates, and manages ticket sales for live entertainment in the United States and internationally. It also owns and operates entertainment venues, and manages the careers of music artists.

Want to dig deeper into these stocks?